CHTR vs FDMT · P/E 11, rev $55.09B vs rev $37.0K
Charter Communications Inc (CHTR) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CHTR and FDMT stock pages for the full models.
Not investment advice.